Navigation Links
Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events
Date:4/25/2011

AMSTERDAM, April 25, 2011 /PRNewswire/ -- Leading events organiser UBM Live is today happy to announce that, following the postponement of its CPhI, ICSE, P-MEC and BioPh Japan events in Tokyo as a result of the recent earthquake in northern Japan, the events have now been rescheduled and will be held from 13-15 July 2011 at the Intex Osaka Exhibition Centre.  The Japanese business community is intent on picking itself up as quickly as possible from the effects of the disaster and there is a strong feeling of the need to get back to business as usual. UBM anticipates that the Osaka events will attract over 150 exhibitors and around 8,000 visitors.  

In addition to being Japan's second largest city, Osaka is the center of the Kansai area, one of the main regions in Japan for pharmaceutical R&D and manufacturing, with numerous Japanese and multinational pharmaceutical companies having their head office, factories and R&D centers located there, and in surrounding cities. The events are conveniently located for visitors from prefectures in the Kansai region such as Osaka, Hyogo, Kyoto, Tokushima and Shiga, as well as other key pharmaceutical manufacturing prefectures with easy access to Osaka such as Toyama, Shizuoka, Aichi, Gifu and Yamaguchi.

"Following our initial announcement regarding the unfortunate postponement of the events in Tokyo, we received many requests from exhibitors asking if there was some way that we could facilitate an opportunity for them to meet their clients in Japan this year," commented Annemieke Timmers, CPhI Brand Director. "We also received unanimous feedback from our Japanese customers and we recognize that it is precisely at times such as this that CPhI Japan, along with ICSE, P-MEC and BioPh Japan, could help contribute towards the stable supply of pharmaceutical products in what is the second largest pharma market after the United States."

"After careful consideration, we decided that it was important to reschedule the events in 2011 in order to provide the Japanese market with a recognized, industry-leading platform for networking and learning by bringing together representatives of the international Pharma community in one location, allowing them to do business, meet with existing clients and new prospects, as well as stay informed of developments in the industry," added Haf Cennydd, Brand Director ICSE, P-MEC and BioPh. "We are currently putting together a schedule of conference sessions which will run alongside the events over the three-day period. These will cover a wide variety of topics relevant to each of the co-located shows that will enhance the educational experience for exhibitors and visitors alike."

Further information on CPhI, ICSE, P-MEC and BioPh Japan can be found at www.cphijapan.com.

UBM Live's annual schedule of global pharma events also includes South America (August 24-26, 2011, Transamerica Expo Center, Sao Paulo, Brazil), Worldwide (October 25-27, Messe Frankfurt, Germany) and India (November 30- December 2, 2011, Bombay Exhibition Centre, Mumbai, India). The Japan events will return to Tokyo in 2012 and will run from 21-23 March at Tokyo Big Sight. Further information about CPhI, ICSE, P-MEC and BioPh can be found online at www.icsexpo.com, www.cphi.com, www.p-mec.com and www.bioph-online.com.

Notes for Editors:

  • With offices in the UK, Netherlands, USA, UAE and Brazil, UBM Live operates a number of market leading exhibitions, awards, websites/online products and publications in twenty different business sectors. UBM Live is part of UBM Ltd, a leading global media company listed on the London Stock Exchange.  See www.ubmlive.com

  • UBM Ltd is a leading global business media company. We inform markets and bring the world's buyers and sellers together at events, online, in print and provide them with the information they need to do business successfully. Our 6,000 staff in more than 30 countries are organised into specialist teams that serve these communities, helping them to do business and their markets to work effectively and efficiently. See www.ubm.com


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing
2. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
3. New Analysis Finds Antidepressants Boost Patient Adherence to Hepatitis C Treatment
4. InspireMD Boosts MGuard Production Capacity
5. PaedRegCliNet e.V.: A Boost for Safe Pediatric Medications
6. Prolong Pharmaceuticals Boosts Executive Team
7. ALS Research Gets a $4.1 Million Boost from CVS/pharmacy Fundraising Campaign
8. Electronic Recordkeeping Boosts Patient Safety, Saves DMC More Than $5 Million - For Second Straight Year
9. George Soros to Boost Civil Society Response in Flood Affected Areas of Pakistan
10. Study Seeks Volunteers to Measure Safety of Treatment Boost for Patients with Oropharyngeal Cancer
11. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... -- --> --> ... Spectroscopy Market by Industry (Oil & Gas, Petrochemical, Pharmaceutical, Water ... & Mining, and Others), And Geography - Global Forecast ... expected to grow to USD 3.9 Billion by 2020, ... 2020. Browse 82 market data Tables and ...
(Date:2/10/2016)... Feb. 10, 2016  Resolve Therapeutics, LLC, a ... approaches to the treatment of lupus and Sjogrens ... multiple ascending dose study in patients with systemic ... --> --> ... ascending dose study of RSLV-132 in 32 subjects ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 10, 2016 , ... Dr. Peyman Ghasri, skin doctor ... variety of comprehensive procedures for facial enhancement. The treatments now available at Castle ... and nasal reshaping. , As a result, patients can improve virtually every ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of ... (ALCA) to conduct a survey that takes a closer look at cases of TBI ... prevalence and causes of TBI among the aging population, and identifies the challenges associated ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing list ... seven other locations throughout the Southeast, from Orlando to Huntsville and in between. ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after ... the investment community following the release at 4:30 PM ET. Investors interested in participating ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association for Medical ... Jan Fox will serve as keynote speaker at the organization’s 2016 Spring Conference. ... to more effectively communicate with their own organizational staff and leadership. , ...
Breaking Medicine News(10 mins):